Evaluation of the CYP3A and CYP2B6 Drug-Drug Interaction Potential of Lemborexant

Landry, I; Aluri, J; Nakai, K; Hall, N; Miyajima, Y; Ueno, T; Dayal, S; Filippov, G; Lalovic, B; Moline, M; Reyderman, L

Landry, I (corresponding author), Eisai Inc, Neurol Business Grp NBG, Clin Pharmacol & Translat Med, 100 Tice Blvd, Woodcliff Lake, NJ 07677 USA.

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, ; ():